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A significant protein tyrosine phosphatase (PTP) activity was found to be associated with the cytoskeleton of thrombin-stimulated platelets. 
Translocation of the enzyme became maximal witbin l-2 min of thrombin stimulation and was suppressed by cytochalasin D or upon inhibition 
of aggregation. Immunoblotting as well as immunoprecipitation revealed that a PTP with two SH2 domains (SH-PTPl) displayed the same behaviour, 
translocation to the cytoskeleton showing the same time course as that observed for ~~60”“‘. We conclude that SH-PTPl might represent a critical 
enzyme in the complex interplay between the various proteins regulating protein tyrosine phosphorylation in the cytoskeletal matrix. 
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1. Introduction 
Besides regulating cell growth, differentiation and 
transformation [1,2], protein tyrosine phosphorylation is 
also important for the function of terminally differenti- 
ated cells such as platelets [3,4]. These anucleated cells 
contain a number of non-receptor PTK such as pp60”“” 
and related proteins [4,5}, ~~72’~~ [6], or focal adhesion 
kinase (ppl25@) [7]_ Tyrosine phosphorylation results in 
the formation of protein complexes via speci& recogni- 
tion of well defined phosphotyrosyl residues by proteins 
containing SH2 domains [8,9]. Most of these proteins 
also contain SH3 regions, which are thought to direct 
their association with cytoskeieton [S-lo]. In activated 
platelets, this kind of association was previously de- 
scribed for various phosphoinositide kinases (including 
PI 3kinase), phospholipase C, diacylglycerol kinase, 
pp60”” and ppl2sf”k [l l-171. This was also observed in 
nucleated cells [10,18-201, leading to the suggestion that 
recruitment of various signalling proteins to the cyto- 
skeleton might enable multiple interactions and cascade 
events on the cytoskeletal matrix [19]. 
PTP are very critical in regulating the level of tyrosine 
phosphorylation. Two families of PTP have been defined 
and include transmembrane and intracellular enzymes 
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(reviewed in [21,22]). Previous studies on the biochemis- 
try of platelet PTP included the characterization of a 
53-kDa PTP displaying a membrane localization [23] as 
well as the identification of PTP-1B as a substrate of 
calpain in thrombin-stimulated platelets [24]. In addi- 
tion, two other PTP appear particularly interesting for 
platelets, specially when considering possible interac- 
tions with the cytoskeleton: PTPHl, also called MEG, 
is a 104106-kDa protein identified by molecular cloning 
in HeLa cells and rnega~~~~es, and displaying ho- 
mology with the cytoskeletal proteins band 4.1, ezrin and 
talin [25,26]; SH-PTPl, also referred to as PTPlC, HCP, 
SHP or PTPN6, is predominantly expressed in hemato- 
poietic cells and contains two SH2 domains [2’7-301. 
In the present study, we have investigated the subcellu- 
lar distribution of platelet PTP activity, with special 
interest for its possible association with cytoskeleton 
during the course of thrombin-stimulated aggregation. 
Owing to its potential participation in signalling com- 
plexes via its SH2 domains, SH-PTPl was more speck- 
tally investigated. 
2. Materials and methods 
2.1. Materials 
Poly(Glu,Tyr) (41) (molecular mass 20-50 kDa), synthetic peptide 
RGDS, cytochalasin D, human thrombin, anti-rabbit IgG (whole mol- 
ecule) alkaline phosphatase conjugate antibody, anti-rabbit IgG perox- 
idase conjugate and anti-mouse IgG peroxidase conjugate were pur- 
chased from Sigma. [y-‘2P]ATP and ECL (immunoblotting detection 
system) were from Amersham. An immunoafhnity-purified, rabbit pol- 
yclonal antibody specific for SH-PTPl was obtained from UBI (Lake 
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Placid, NY, USA). Protein A-Sepharose CL4B was purchased from 
Pharmacia-LKB, Uppsala, Sweden. 
2.2. Incubation of platelet suspensions and isolation of platelet 
cytoskeleton 
Platelet suspensions (5 x 10’ cells/ml) in Tyrode’s albumin buffer 
containing 1 mM CaCl, were prepared from human blood as previously 
described 1121. After equilibration for 5 min at 37”C, platelets were 
incubated in the presence of thrombin (1 NIH unit/ml) for appropriate 
times. In some experiments, the 5-min preincubation was performed in 
the presence of RGDS (200 &ml), EDTA (5 mM) or cytochalasin D 
(20 PM). Incubations were terminated by addition of an equal volume 
of ‘CSK buffer’ [12] containing Triton X-100 and cytoskeletons were 
isolated as in [12]. 
2.3. Determination of PTP activity 
[‘*P]Phosphotyrosyl poly(Glu,Tyr) was used as a substrate of PTP as 
in [31], except in experiments dealing with immunoprecipitated 
SH-PTPl (see Fig. 3), where it was replaced byp-nitrophenyl phosphate 
[311. 
SH-PTPl could also be detected by immunoprecipitation 
followed by immunoblotting. Here again, the 68-kDa 
protein was found to increase in the cytoskeleton of 
thrombin-stimulated cells with a time course of translo- 
cation identical to that previously observed (Fig. 3A). 
Interestingly, the immunoprecipitate was determined for 
hydrolytic activity towards p-nitrophenyl phosphate, 
which is currently used as a convenient substrate of var- 
ious PTP [31,38]. As illustrated in Fig. 3B, immunopre- 
cipitated phosphatase activity was found to associate to 
the cytoskeleton of thrombin-stimulated cells with a time 
course identical to that previously observed for SH- 
PTPl and pp60’“‘. 
2.4. Protein determination, gel electrophoresis and immunoblotting 
Protein content was determined as in [32]. Proteins were separated 
by electrophoresis n a 10% polyacrylamide gel under reducing condi- 
tions [33] and blotted onto nitrocelhdose as in [34]. Immunodetection 
was performed with a polyclonal antibody specitic for SH-PTPl 
(0.2 &ml) or the monoclonal antibody Ab-1 specific for pp60’~“’ 
(1 ~&ml). Final detection was achieved using anti-rabbit or anti-mouse 
immunoglobulins conjugated either to horseradish peroxidase (ECL 
system) or to alkaline phosphatase as secondary antibodies. 5-Bromo- 
4&loro-3- indolyl phosphate was used as substrate of alkaline phos- 
phatase. 
2.5. Immunoprecipitation of SH-PTPl 
Several studies previously showed that activation- 
dependent association to platelet cytoskeleton of a num- 
ber of proteins actually involved integrin a,,,,& and actin 
polymerization. This is the case for instance for pp60”*” 
or PI 3-kinase [13-171. From data presented in Fig. 4A, 
the same behaviour was observed for platelet PTP activ- 
ity, since the tetrapeptide RGDS as well as EDTA, which 
inhibit fibrinogen binding to integrin CC~~,@~ by different 
mechanisms, both abolished the translocation of PTP 
activity to platelet cytoskeleton. Moreover, Fig. 4B 
shows that RGDS abrogated the association of SH- 
PTPl with platelet cytoskeleton promoted by thrombin 
SH-PTPl was immunoprecipitated from cytoskeletons olubilized in 
‘RIPA buffer’ [35,36], using 2 &ml of rabbit polyclonal antibody 
specific for SH-PTPl . 800 CSK-proteins 
3. Results 600 - 
Using [32P]phosphotyrosyl poly(Glu-Tyr) as a sub- 
strate, platelets displayed a significant PTP activity 
(325 f 8 pmol x min-’ per 10’ cells, mean f SE-M.), 
which was distributed between cytosol(60%) and partic- 
ulate fraction (40%, data not shown). PTP activity re- 
mained very low in cytoskeletons from resting platelets 
but increased significantly upon thrombin stimulation, 
attaining S-fold the basal level within 2 min (Fig. 1A). By 
comparison (Fig. lB), the increase of total cytoskeletal 
protein, which mainly reflects actin polymerization, oc- 
curred within the first seconds and attained 3. to 4-fold 
the basal level within 10-30 s. This suggests that associ- 
ation of PTP activity with platelet cytoskeleton was not 
a passive event resulting from non specific attachment of 
the enzyme(s) to the newly generated actin filaments. 
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By immunoblotting of subcellular fractions from rest- 
ing platelets, a specific polyclonal antibody recognized a 
protein displaying the expected size of SH-PTPl (67-68 
kDa). In agreement with previous observations [37], a 
stronger signal was detected in the membrane fraction 
compared to cytosol (not shown). As shown in Fig. 2, 
SH-PTPl was barely detected in the cytoskeleton of rest- 
ing platelets, but following thrombin addition it dis- 
played a stronger immunological signal, which became 
maximal after 1 min of thrombin stimulation. Finally, 
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Fig. 1. Translocation of proteins and PTP activity to the cytoskeleton 
of thrombin-stimulated platelets. Platelets were incubated for the indi- 
cated times in the presence of thrombin (1 NIH tit/ml), cytoskeletons 
were isolated and determined for PTP activity (A) and for protein 
content (B). Data are means + S.E.M. of 3 different experiments. 
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Fig. 2. Trauslocation of SH-PTPI to the cytoskeleton of thrombin- 
stimulated platelets. Platelets were incubated as described in Fig. 1 and 
cytoskeletons were analysed by ~unoblotting for the presence of 
SH-PTPl, detection being achieved by alkaline phosphatase. Data are 
representative of at least 5 experiments with identical results. 
addition. In the presence of cytochalasin D, the throm- 
bin-stimulated increase of PTP activity sedimenting with 
Triton-insoluble fraction was also suppressed (not 
shown). 
4. Dimion 
PTP can thus be added to the number of signalling 
proteins able to redistribute to cytoskeleton of activated 
platelets. The observation is of importance owing to the 
fact that platelets undergo dramatic increase in tyrosine 
phosphorylation under appropriate stimulation [3,4]. 
The time course of the association of both PTP activity 
and SH-PTPl is very similar to that described for phos- 
pholipase C, diacylglycerol kinase, various phosphoinos- 
itide kinases (including PI 3kinase and its regulatory 
subunit ~85) as well as pp60”“” and ~~12s’~ [7,11-171. 
In addition, like for pp60’“” and PI 3-kinase, transloca- 
tion of PTP to the c~oskeleton requires both aggrega- 
tion and actin polymerization, as deduced from the in- 
hibitory effects of the peptide RGDS, of EDTA and of 
cytochalasin D. There is thus some circumstantial corre- 
lation between the appearance of PTP activity and of 
SH-PTPl in platelet cytoskeleton, the third wave of tyro- 
sine phosphorylation described in aggregating platelets 
[3,4] and the thrombin-stimulated increase of PI 
3,4&rphosphate synthesis [39]. However, the possible 
molecular mechanisms linking these events still remain 
unclear. A recent study of Pumiglia and Feinstein [17l 
showed that translocation of integrin ~,//3~ and of 
pp60” does not occur in moderate-sized aggregates but 
requires the latter extensive formation of large aggre- 
gates. We can thus suggest hat association of SH-PTPl 
to the cytoskeletal matrix follows the same rule and 
probably involves the same mechanism. A common 
structural feature between pp60”“’ and ~85 is the pres- 
ence of SH2 and SH3 domains. The mechanisms involv- 
ing SH3 are probably not exclusive, but one can suggest 
that various signalling proteins might associate to the 
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cytoskeleton through their SH3 domains, whereas others 
could bind via their SH2 domains to phospho~rosyl 
proteins present in cytoskeletal complexes. This is prob- 
ably the case for SH-PTPl. 
As previously suggested [19], it is tempting to speculate 
that the cytoskeleton forms a matrix onto which attached 
proteins become able to interact with each other. A fur- 
ther step in understanding the role of SH-PTPl will be 
to define its natural substrate, which might belong to a 
number of other phosphotyrosyl proteins also found in 
the cytoskeleton of activated platelets. A first candidate 
could be pp60”“, however dephospho~lation of Y527, 
which activates the kinase activity of pp60”“‘“, actually 
precedes its translocation to cytoskeleton [16]. Two 
proteins were found to undergo integrin-dependent 
dephosphorylation in response to thrombin or to a 
thromboxane-A, analogue [40]. It would thus be interest- 
ing to investigate whether these two phosphotyrosyl pro- 
teins also undergo a translocation to cytoskeleton. 
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Fig. 3. I~unopr~pi~tion of SH-PTPl and phospbatase activity 
from cystoskeletons i olated from thrombin-stimulated platelets. Plate- 
let were incubated as described in Fig. 1, cytoskeletons (CSK) were 
isolated and SW-PTPl was immunoprecipitated as described in section 
2. Panel A shows the detection of SH-PTPl by immunoblotting using 
alkaline phosphatase. Note the presence of immunoglobulin-G heavy 
chain (IgG) in the immunoprecipitated material below SH-PTPl . Panel 
B represents the phosphatase activity of the immunoprecipitate as de- 
termined withpnitrophenyl phosphate as substrate. Data are represen- 
tative of two experiments with identical results. 
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Fig. 4. Inhibition by RGDS and EDTA of the translocation to cyto- 
skeleton of PTP activity and SH-PTPl . Platelets were stimulated with 
thrombin as described in Fig. 1 after a 5 min preincubation without any 
addition (CSK/Thro, hatched bars), or in the presence of 200 &ml 
RGDS (CSK/RGDS/Thro, filled bars), or in the presence of 5 mM 
EDTA (CSK/EDTA/Thro, dashed bars). In panel A, PTP activity was 
determined on cytoskeletons. Data are means f S.E.M. of three differ- 
ent experiments. Panel B shows detection by immunoblotting of SH- 
PTPl in the cytoskeletons of platelets incubated with RGDS and 
thrombin. The right lane (4 min -) corresponds to platelets incubated 
with thrombin in the absence of RGDS. Detection was achieved using 
ECL system. 
Finally, our observation might offer some clue to un- 
derstand the regulation of SH-PTPl. In vitro studies 
suggested three possible mechanisms, including prote- 
olytic cleavage [38], tyrosine phosphorylation [41], as 
well as interaction with anionic phospholipids [37]. In 
contrast to pp60’“” [42] and PTP-1B [24], we did not 
detect any proteolytic cleavage of SH-PTPl. The second 
possibility would fit with the time course of pp60”” 
translocation, although other protein tyrosine kinases 
are potential candidates to phosphorylate SH-PTPl. Fi- 
nally, previous studies reported the association of vari- 
ous anionic phospholipids with cytoskeleton or some 
cytoskeletal proteins [4446]. These might include 
phosphatidylserine [45], phosphatidic acid [47], or pol- 
yphosphoinositides [39,48]. 
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